Deborah Waterhouse, CEO, ViiV Healthcare and President, Global Health, GSK, said: “At ViiV Healthcare we believe that everyone, no matter where they live, should have the freedom to be their authentic ...

Also Read: Just After Pfizer’s RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population Specialty Medicine sales increased ...

(Reuters) -GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory syncytial virus (RSV) and shingles vaccines in the third quarter, ...

Bolton continued their superb form by beating Stevenage 4-1 away in Sky Bet League One. Wanderers, who have now won six and drawn one of their last eight games, were set on their way by two goals ...

GlaxoSmithKline said its key brands held their market share and continued to stay in line with the respective category performance. GlaxoSmithKline Pharmaceuticals on October 29 reported a 16 ...

Bolton travel to Stevenage in League One on Tuesday night, with Ian Evatt's side looking to jump into the play-off spots. Bolton, who lost in the play-off final against Oxford United last season ...

GSK Plc acquired an experimental drug from Chinese biotech firm Chimagen Biosciences for as much as $850 million, adding to the British drugmaker’s pipeline of potential treatments for lupus.

Oct 29 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens new tab reported a higher second-quarter adjusted profit on Tuesday, driven by strong demand for its generic drugs and ...

Iain led discussions with GSK in respect of the University of Cambridge–GSK open innovation drug discovery initiative based at the Stevenage Bioscience Catalyst, founded (with others) Apollo ...

Dr Sally Ann Forsyth OBE, CEO of SBC, said: “Stevenage Bioscience Catalyst is truly honoured to win Most Successful Science Park (Small) Award, and for the SBC graduate Autolus Therapeutics to have ...